Table IX.

Association between the expression of miR-429 and clinicopathological parameters of gastric cancer.

Variable	Cases, n (%)	Expression of miR-429, median ± range	P-value
Gender			0.208
Male	32 (57)	2.272±0.334
Female	24 (43)	3.130±0.637
Age, years			0.047*
≤50	18 (32)	3.602±0.763
>50	38 (68)	2.184±0.317
Tumor size, cm			0.746
≤5	31 (55)	2.739±0.531
>5	25 (45)	2.518±0.368
Degree of differentiation			0.705
Well and moderately	17 (30)	2.445±0.521
Poorly	39 (70)	2.725±0.426
TNM stage			0.363
I/II	27 (48)	2.959±0.584
III/IV	29 (52)	2.343±0.351
Lymph-node status			0.074
No metastasis	6 (11)	3.169±0.756
Metastasis	50 (89)	2.216±0.262

miR, microRNA; TNM, tumor node metastasis.